Empro Group (EMPG) Fair Value & Analysis
Healthcare · US · Market cap $143M
Fair value as of: Jun 24, 2026
Analysis
Empro Group (EMPG) currently trades at $17.36, while our model-based Fair Value estimate is $1.80 — implying the stock looks roughly 89.6% overvalued today. We read business quality at 88/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Empro Group Inc., through its subsidiary, sells healthcare and beauty products in Malaysia and internationally. The company offers eyebrow pencils, skincare and antibacterial moisturizing mist products, surgical face masks, nitrile gloves, test kits, lips natural recovery cream, and black diamond eyeliners under the Empro, Premio, SpaceLift, and Mios brands. It sells its products through retails stores and online retail. The company was founded in 2004 and is based in Shah Alam, Malaysia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Empro Group (EMPG) undervalued?
What is the fair value of EMPG?
What is the quality score of EMPG?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.